Advertisement

Organisation › Details
Roche (Group)
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the tenth consecutive year, Roche has been recognised as the most sustainable company in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI). The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2018 employed about 94,000 people worldwide. In 2018, Roche invested CHF 11 billion in R&D and posted sales of CHF 56.8 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. *
![]() |
Start | 1996-01-01 existent |
![]() |
Industry | pharmaceutical |
Industry 2 | diagnostics (medical/biological) | |
![]() |
Person | Schwan, Severin (Roche 2008 CEO before CEO of division Roche Diagnostics) |
Person 2 | Hippe, Alan (Roche 201104– CFO before ThyssenKrupp + Continental + Fraport) | |
![]() |
Region | Basel BS |
Country | Switzerland | |
Street | 124 Grenzacherstr. | |
City | 4070 Basel BS | |
Tel | +41-61-688-1111 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | I: 50,001 to 100,0 (2018-12-31) |
Currency | CHF | |
Annual sales | 56,846,000,000 (sales, consolidated (2018) 2018-12-31) | |
Profit | 10,865,000,000 (2018-12-31) | |
* Document for �About Section�: Roche. (1/31/19). "Press Release: Roche Reports Very Strong Results in 2018. Group Sales Increase 7% at Constant Exchange Rates and in Swiss Francs". Basel. | ||
Record changed: 2023-01-01 |
Advertisement

More documents for Roche (Group)
- [1] Jnana Therapeutics Inc.. (11/15/22). "Press Release: Jnana Therapeutics Announces Second Collaboration with Roche to Address Challenging-to-Drug Targets in Cancer, Immune-Mediated and Neurological Diseases". Boston, MA....
- [2] MorphoSys AG. (11/14/22). "Press Release: MorphoSys’ Licensing Partner Roche Provides Update on Phase 3 GRADUATE Program for Gantenerumab in Early Alzheimer’s Disease". Planegg....
- [3] Roche. (11/14/22). "Press Release: Roche Provides Update on Phase III GRADUATE Programme Evaluating Gantenerumab in Early Alzheimer’s Disease". Basel....
- [4] Hookipa Pharma Inc.. (10/20/22). "Press Release: Hookipa Announces Strategic Collaboration and License Agreement with Roche to Develop Novel Arenaviral Immunotherapy for KRAS-mutated Cancers". New York, NY & Vienna....
- [5] Arsenal Biosciences, Inc.. (9/27/22). "Press Release: Arsenal Biosciences Announces Joint Discovery Collaboration with Genentech to Identify Features of Successful T-Cell Therapies for Oncology". South San Francisco, CA....
- [6] PhoreMost Ltd.. (9/6/22). "Press Release: PhoreMost Enters Multi-project Drug Target Discovery Collaboration with Roche". Cambridge....
- [7] Roche. (8/23/22). "Press Release: Roche Launches a Digital PCR System, a Powerful New Diagnostics Platform in the Fight against Cancer and other Diseases". Basel....
- [8] Poseida Therapeutics, Inc.. (8/3/22). "Press Release: Poseida Therapeutics Announces Strategic Global Collaboration with Roche Focused on Allogeneic CAR-T Cell Therapies for Hematologic Malignancies". San Diego, CA....
- [9] Forbion Capital Partners. (7/20/22). "Press Release: Forbion Appoints Dr. Peter Høngaard Andersen as Operating Partner and Dr. Matt Cooper as Venture Partner". Naarden....
- [10] Apertura Gene Therapy LLC. (7/14/22). "Press Release: Apertura Appoints Gene Therapy Executive Joseph La Barge as Chief Executive Officer". New York, NY & Cambridge, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top